Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous syst…
$3.49+9.06%
报价 2026-11-06
市值
$100.5M
EV
$92.5M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -70.5%
$2.53$11.83
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Biotechnology| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| NTHINeonc Technologies Holdings, Inc. | $100.5M | +9.1% | -100.0% | 0% | – | – | – | |
| IMUXImmunic, Inc. | $105.7M | +5.9% | -96.9% | 0% | – | – | – | |
| PYXSPyxis Oncology, Inc. | $105.2M | +3.1% | -100.0% | 99.8% | – | – | – | |
| NBPI-Mab | $104.8M | +0.2% | – | 0% | – | – | – | |
| HURATuHURA Biosciences, Inc. | $103.9M | +1.2% | +50.0% | 0% | – | – | – | |
| NRXPNRx Pharmaceuticals, Inc. | $103M | +4.8% | +800.8% | 32.7% | – | – | – | |
| BDTXBlack Diamond Therapeutics, Inc. | $99.4M | +4.5% | -89.9% | 0% | – | – | – | |
| UNCYUnicycive Therapeutics, Inc. | $97.2M | +2.0% | +3460.0% | 0% | – | – | – | |
| EQEquillium, Inc. | $95.7M | +13.5% | +41.8% | 0% | – | – | – | |
| 同行中位数 | – | – | +41.8% | 0% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。
研究材料
Filing 摘要
电话会纪要摘要
暂无纪要摘要。